Pemetinib/pemetinib generics: a new focus on affordable anti-cancer drugs

Pemigatinib/Pemigatinib (Pemigatinib), a new drug that has emerged in the field of anti-cancer, already has a generic version. These generic drugs come into being after the patent protection period of the original drugs expires. They are very similar in ingredients to the expensive original drugs, but they are more affordable. Lucius Pharmaceuticals in Laos has taken the lead in producing generic versions of pemetinib, providing patients with a more economical treatment option.

Pemetinib, as a targeted drug for malignant tumors such as advanced cholangiocarcinoma, has remarkable efficacy and brings new hope to many patients. It effectively curbs the growth and spread of cancer cells by precisely inhibiting the specific signaling pathways of tumor cells. Although there may be some side effects during use, the advantages of pemetinib compared with traditional treatments are self-evident.

However, the high price of original drugs often prohibits many patients. Fortunately, the emergence of generic drugs has broken this deadlock. Currently, the price of each box of generic pemetinib produced by Lucius Pharmaceutical Factory in Laos (specification: 4.5mg*14 tablets) is around RMB 1,000 (the actual price may be adjusted due to exchange rate fluctuations). In comparison, the original drug pemetinib, which is marketed in China and is not covered by medical insurance, costs more than 30,000 yuan per box. In overseas markets, the price of the original drug with the same specification reaches an astonishing around 70,000 yuan (the price will also fluctuate due to the exchange rate).

The advent of generic pemetinib has undoubtedly brought good news to the majority of patients. While maintaining similar efficacy to the original drug, its more affordable price makes this advanced treatment option affordable for more patients. For patients who intend to choose overseas versions of original drugs or generic drugs, it is crucial to ensure the formality of drug purchase channels. For more overseas drug prices and information, consult Yaode Medical Consultant.